News

Filter

Current filters:

Nanobiotix

Nanobiotix to receive $1 million milestone after global trial expanded

Nanobiotix to receive $1 million milestone after global trial expanded

08-10-2014

French nanomedicine company Nanobiotix says that its partner PharmaEngine will join its pivotal trial…

Asia-PacificFranceNanobiotixNBTXR3OncologyPharmaceuticalPharmaEngineResearch

Nanobiotix expands into USA with office in Boston life sciences cluster

Nanobiotix expands into USA with office in Boston life sciences cluster

22-09-2014

France-based Nanobiotix, a clinical-stage nanomedicine company pioneering novel approaches for the local…

BiotechnologyFinancialFranceNanobiotixOncologySanofiUSA

Nanobiotix appoints Thierry Otin as Head of Manufacturing and Supply

Nanobiotix appoints Thierry Otin as Head of Manufacturing and Supply

29-04-2014

French nanomedicine company Nanobiotix has announced the appointment of Thierry Otin as Head of Manufacturing…

BiotechnologyBoardroomFranceNanobiotix

Nanobiotix outlines development plan for NBTXR3 in soft tissue sarcoma

11-02-2014

Nanobiotix, a French nanomedicine company focused on cancer therapy, has announced today its development…

BiotechnologyNanobiotixNBTXR3OncologyResearch

PharmaEngine and Nanobiotix sign Asia-Pacific deal for NBTXR3

08-08-2012

French nano-medicines group Nanobiotix has entered into a strategic partnership with PharmaEngine (TWO:…

Asia-PacificBiotechnologyLicensingNanobiotixNBTXR3OncologyPharmaceuticalPharmaEngine

Nanobiotix starts clinical trial with lead product for soft tissue sarcoma

15-09-2011

Nanobiotix, an emerging French nanomedicine company focused on cancer therapy, says that its lead compound,…

NanobiotixOncologyPharmaceuticalRegulationResearch

COMPANY SPOTLIGHT

Menarini

Back to top